BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 9746591)

  • 21. A long-lasting protective immunity against chronic toxoplasmosis in mice induced by recombinant rhoptry proteins encapsulated in poly (lactide-co-glycolide) microparticles.
    Xu Y; Zhang NZ; Wang M; Dong H; Feng SY; Guo HC; Zhu XQ
    Parasitol Res; 2015 Nov; 114(11):4195-203. PubMed ID: 26243574
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DNA immunization with eukaryotic initiation factor-2α of Toxoplasma gondii induces protective immunity against acute and chronic toxoplasmosis in mice.
    Chen J; Huang SY; Zhou DH; Li ZY; Petersen E; Song HQ; Zhu XQ
    Vaccine; 2013 Dec; 31(52):6225-31. PubMed ID: 24183979
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protection via a ROM4 DNA vaccine and peptide against Toxoplasma gondii in BALB/c mice.
    Han Y; Zhou A; Lu G; Zhao G; Wang L; Guo J; Song P; Zhou J; Zhou H; Cong H; He S
    BMC Infect Dis; 2017 Jan; 17(1):59. PubMed ID: 28077075
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protective immunity induced by a DNA vaccine expressing eIF4A of Toxoplasma gondii against acute toxoplasmosis in mice.
    Chen J; Huang SY; Li ZY; Yuan ZG; Zhou DH; Petersen E; Zhang NZ; Zhu XQ
    Vaccine; 2013 Mar; 31(13):1734-9. PubMed ID: 23370151
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Construction and immunogenicity of pseudotype baculovirus expressing Toxoplasma gondii SAG1 protein in BALB/c mice model.
    Fang R; Feng H; Nie H; Wang L; Tu P; Song Q; Zhou Y; Zhao J
    Vaccine; 2010 Feb; 28(7):1803-7. PubMed ID: 20018269
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vaccine potential of antigen cocktails composed of recombinant Toxoplasma gondii TgPI-1, ROP2 and GRA4 proteins against chronic toxoplasmosis in C3H mice.
    Picchio MS; Sánchez VR; Arcon N; Soto AS; Perrone Sibilia M; Aldirico MLA; Urrutia M; Moretta R; Fenoy IM; Goldman A; Martin V
    Exp Parasitol; 2018 Feb; 185():62-70. PubMed ID: 29309783
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Toxoplasma gondii: the vaccine potential of three trivalent antigen-cocktails composed of recombinant ROP2, ROP4, GRA4 and SAG1 proteins against chronic toxoplasmosis in BALB/c mice.
    Dziadek B; Gatkowska J; Grzybowski M; Dziadek J; Dzitko K; Dlugonska H
    Exp Parasitol; 2012 May; 131(1):133-8. PubMed ID: 22445587
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vaccination with replication-deficient recombinant adenoviruses encoding the main surface antigens of toxoplasma gondii induces immune response and protection against infection in mice.
    Caetano BC; Bruña-Romero O; Fux B; Mendes EA; Penido ML; Gazzinelli RT
    Hum Gene Ther; 2006 Apr; 17(4):415-26. PubMed ID: 16610929
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of protective immunity induced by DNA vaccination with genes encoding Toxoplasma gondii GRA17 and GRA23 against acute toxoplasmosis in mice.
    Zhu WN; Wang JL; Chen K; Yue DM; Zhang XX; Huang SY; Zhu XQ
    Exp Parasitol; 2017 Aug; 179():20-27. PubMed ID: 28625894
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intranasal immunization with Toxoplasma gondii SAG1 induces protective cells into both NALT and GALT compartments.
    Velge-Roussel F; Marcelo P; Lepage AC; Buzoni-Gatel D; Bout DT
    Infect Immun; 2000 Feb; 68(2):969-72. PubMed ID: 10639474
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunogenicity and protective efficacy of two recombinant pseudorabies viruses expressing Toxoplasma gondii SAG1 and MIC3 proteins.
    Nie H; Fang R; Xiong BQ; Wang LX; Hu M; Zhou YQ; Zhao JL
    Vet Parasitol; 2011 Sep; 181(2-4):215-21. PubMed ID: 21632181
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Major role for CD8 T cells in the protection against Toxoplasma gondii following dendritic cell vaccination.
    Guiton R; Zagani R; Dimier-Poisson I
    Parasite Immunol; 2009 Oct; 31(10):631-40. PubMed ID: 19751475
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular characterization and protective immunity of rhoptry protein 35 (ROP35) of Toxoplasma gondii as a DNA vaccine.
    Zhang Z; Li Y; Liang Y; Wang S; Xie Q; Nan X; Li P; Hong G; Liu Q; Li X
    Vet Parasitol; 2018 Aug; 260():12-21. PubMed ID: 30197008
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of Protective Immune Response Induced by a DNA Vaccine Encoding GRA8 against Acute Toxoplasmosis in a Murine Model.
    Chu JQ; Huang S; Ye W; Fan XY; Huang R; Ye SC; Yu CY; Wu WY; Zhou Y; Zhou W; Lee YH; Quan JH
    Korean J Parasitol; 2018 Aug; 56(4):325-334. PubMed ID: 30196664
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DNA vaccine encoding the Toxoplasma gondii bradyzoite-specific surface antigens SAG2CDX protect BALB/c mice against type II parasite infection.
    Zhang M; Zhao L; Song J; Li Y; Zhao Q; He S; Cong H
    Vaccine; 2013 Sep; 31(41):4536-40. PubMed ID: 23933373
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cutting edge: dendritic cells are essential for in vivo IL-12 production and development of resistance against Toxoplasma gondii infection in mice.
    Liu CH; Fan YT; Dias A; Esper L; Corn RA; Bafica A; Machado FS; Aliberti J
    J Immunol; 2006 Jul; 177(1):31-5. PubMed ID: 16785494
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A recombinant pseudorabies virus expressing TgSAG1 protects against challenge with the virulent Toxoplasma gondii RH strain and pseudorabies in BALB/c mice.
    Liu Q; Gao S; Jiang L; Shang L; Men J; Wang Z; Zhai Y; Xia Z; Hu R; Zhang X; Zhu XQ
    Microbes Infect; 2008 Oct; 10(12-13):1355-62. PubMed ID: 18761418
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SAG1 is a host-targeted antigen for protection against toxoplasma gondii infection.
    Seng S; Makala LH; Yokoyama M; Lim C; Choi YH; Suzuki N; Toyoda Y; Nagasawa H
    Pathobiology; 2004; 71(3):144-51. PubMed ID: 15051927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vaccination with recombinant adenoviruses expressing Toxoplasma gondii MIC3, ROP9, and SAG2 provide protective immunity against acute toxoplasmosis in mice.
    Zhang D; Jiang N; Chen Q
    Vaccine; 2019 Feb; 37(8):1118-1125. PubMed ID: 30670302
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Toxoplasma gondii microneme protein 6 (MIC6) is a potential vaccine candidate against toxoplasmosis in mice.
    Peng GH; Yuan ZG; Zhou DH; He XH; Liu MM; Yan C; Yin CC; He Y; Lin RQ; Zhu XQ
    Vaccine; 2009 Nov; 27(47):6570-4. PubMed ID: 19720368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.